Later that year, the UK National Institute for Health and Care Excellence (NICE) replicated our meta-analysis and went on to recommend metformin for adults with type 1 diabetes and a BMI ≥25 kg/m2 who ‘want to improve glucose control while minimising their effective insulin dose’ [27]. This evidence concerns the gene INS and type 1 diabetes mellitus.